Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Tudorza Pressair
| Field | Information |
|---|---|
| Medication Name | Tudorza Pressair |
| Generic Name | Aclidinium Bromide |
| Purpose | Long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) |
| Mechanism of Action | Blocks the action of acetylcholine at muscarinic receptors in the airways, leading to bronchodilation |
| Dosage Forms | Dry powder inhaler (Pressair) |
| Available Strengths | 400 mcg per inhalation |
| Dosage Frequency | One inhalation twice daily |
| Common Side Effects | Headache, cough, upper respiratory infection, sinusitis |
| Serious Side Effects | Paradoxical bronchospasm, acute narrow-angle glaucoma, urinary retention |
| Drug Interactions | Other anticholinergic medications |
| Important Notes | Not for acute symptoms; use a short-acting beta2-agonist for sudden breathing problems. Proper inhaler technique is essential. |
| Storage | Store at room temperature away from moisture and heat. |
| Missed Dose | Take as soon as you remember; if it’s almost time for your next dose, skip the missed dose. Do not double the dose. |
| Alternatives | Spiriva (tiotropium), Incruse Ellipta (umeclidinium), Atrovent (ipratropium) |
Tudorza Pressair Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Spiriva (tiotropium) | Long-acting muscarinic antagonist (LAMA) | Once-daily inhalation for COPD maintenance. |
| Incruse Ellipta (umeclidinium) | Long-acting muscarinic antagonist (LAMA) | Once-daily inhalation for COPD maintenance. |
| Atrovent (ipratropium) | Short-acting muscarinic antagonist (SAMA) | Used for COPD and asthma; shorter duration of action than LAMAs. |
| Combivent Respimat (ipratropium/albuterol) | Combination SAMA/short-acting beta2-agonist (SABA) | Provides both anticholinergic and bronchodilator effects. |
Tudorza Pressair Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Headache | Paradoxical bronchospasm (worsening of breathing) |
| Cough | Acute narrow-angle glaucoma (blurred vision, eye pain, halos around lights) |
| Upper respiratory infection | Urinary retention (difficulty urinating) |
| Sinusitis | Allergic reactions (rash, itching, swelling, difficulty breathing) |
Tudorza Pressair Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Chronic Obstructive Pulmonary Disease (COPD) | One inhalation | One inhalation twice daily | Use the Pressair inhaler device as directed. Do not use more often than prescribed. |
